SCHEMBL7930199

SCHEMBL7930199

COc1cc(C(O)C([NH])=O)cc(OC)c1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.47
TUBB4A P04350 4/20 0.46
TUBB P07437 4/20 0.46
TUBA3C P0DPH7 4/20 0.46
TUBA1B P68363 4/20 0.46
TUBA4A P68366 4/20 0.46
TUBB4B P68371 4/20 0.46
TUBB3 Q13509 4/20 0.46
TUBB2A Q13885 4/20 0.46
TUBB8 Q3ZCM7 4/20 0.46
TUBA3E Q6PEY2 4/20 0.46
TUBA1A Q71U36 4/20 0.46
TUBA1C Q9BQE3 4/20 0.46
TUBB6 Q9BUF5 4/20 0.46
TUBB2B Q9BVA1 4/20 0.46
TUBB1 Q9H4B7 4/20 0.46
CYP3A4 P08684 1/20 0.45
MAPK1 P28482 1/20 0.44
BLM P54132 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1572868 0.83 BLM (0.62) MAPTL3MBTL1TUBB4ATUBBTUBA3C
SCHEMBL1572866 0.83 BLM (0.62) MAPTL3MBTL1TUBB4ATUBBTUBA3C
Potassium Ion SCHEMBL28412864 0.80 MAPT (0.47) MAPTL3MBTL1TUBB4ATUBBTUBA3C
SCHEMBL11706382 0.80 MAPK1 (0.50) MAPTL3MBTL1TUBB4ATUBBTUBA3C
SCHEMBL28639889 0.77 MAPT (0.49) MAPTL3MBTL1TUBB4ATUBBTUBA3C
SCHEMBL18287920 0.76 MAPT (0.56) MAPTL3MBTL1TUBB4ATUBBTUBA3C
SCHEMBL2040575 0.75 CES2 (0.56) MAPTMAPK1BLMNPSR1TSHR
SCHEMBL8115552 0.74 MAPT (0.56) MAPTL3MBTL1TUBB4ATUBBTUBA3C
SCHEMBL8824090 0.74 BLM (0.64) MAPTL3MBTL1TUBB4ATUBBTUBA3C
Dimethylformamide SCHEMBL28191620 0.74 BLM (0.51) MAPTL3MBTL1TUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6228868-B1 ANTICARCINOGENIC AND ANTITUMOR AGENTS ABBOTT LABORATORIES 2001-05-08 US disclosed